Position in NVCR
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,392,802
-$592,185 QoQ
Shares Held
127,780
-16.8% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $80,768,403 across 31 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,120,331 | $47,815,727 | |
| 2 | TNDM |
Tandem Diabetes Care Inc
|
314,653 | $4,748,113 | |
| 3 | EW |
Edwards Lifesciences Corp
|
36,042 | $3,260,359 | |
| 4 | INSP |
Inspire Medical Systems, Inc.
|
55,681 | $2,483,929 | |
| 5 | IRMD |
Iradimed Corp
|
23,617 | $2,256,840 | |
| 6 | 88,958 | $2,213,275 | |||
| 7 | ENOV |
Enovis CORP
|
86,138 | $1,783,056 | |
| 8 | QDEL |
QuidelOrtho Corp
|
87,117 | $1,526,289 |
All Filings in NVCR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,392,802 | 127,780 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,984,987 | 153,518 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $386,740 | 21,727 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $418,627 | 23,492 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $559,316 | 18,769 | Shares | Sole | 2025-02-04 | |
| 2024-03-31 | $1,937,166 | 123,939 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,009,820 | 67,637 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $813,685 | 50,383 | Shares | Sole | 2023-11-14 | |
| 2021-12-31 | $394,019 | 5,248 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $699,691 | 6,023 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $824,671 | 6,239 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||